Uroflowmetry and IPSS Factors Influencing Surgical Decision
100 participantsStarted 2025-09-15
Plain-language summary
This study aims to identify which symptoms or test findings lead men with lower urinary tract symptoms (LUTS) to consider surgical treatment. Male patients who visit the outpatient clinic for LUTS will be asked whether they would consider surgery in the future if their symptoms persist. Along with this, symptom severity scores (IPSS), quality of life scores, and uroflowmetry measurements such as maximum flow rate (Qmax) and post-void residual volume (PVR) will be collected. The goal is to determine which factors are most strongly associated with a desire for surgery. This is an observational, non-interventional study.
Who can participate
Age range
40 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male patients aged 40 years and older
* Presenting with lower urinary tract symptoms (LUTS)
* Able to complete the IPSS questionnaire
* Undergoing uroflowmetry as part of routine evaluation
* Able and willing to provide informed consent
Exclusion Criteria:
* History of urological surgery (e.g., TURP, HoLEP, radical prostatectomy)
* Presence of known prostate or bladder cancer
* Active urinary tract infection at the time of evaluation
* Neurological conditions affecting voiding (e.g., Parkinson's disease, spinal cord injury)
* Inability to perform uroflowmetry or incomplete IPSS data
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Total International Prostate Symptom Score (IPSS) at Baseline
Timeframe: Baseline (at the outpatient clinic visit)
2
Post-Void Residual Urine Volume (PVR)
Timeframe: Baseline (at the outpatient clinic visit)
3
Maximum Urinary Flow Rate (Qmax) Measured by Uroflowmetry
Timeframe: Baseline (at the outpatient clinic visit)
4
Patient Preference for Surgery Based on a Standardized Question
Timeframe: Baseline (at the outpatient clinic visit)